Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rodney Howard Falk, M.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HL130563 (DORBALA, SHARMILA) Apr 1, 2016 - Mar 31, 2020
    NIH/NHLBI
    Molecular Imaging of Primary Amyloid Cardiomyopathy
    Role: Co-Principal Investigator
  2. M01RR000533 (ANTMAN, KAREN) Dec 1, 1978 - Nov 30, 2011
    NIH/NCRR
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Singh V, Cuddy S, Kijewski MF, Park MA, Taylor A, Taqueti VR, Skali H, Blankstein R, Falk RH, Di Carli MF, Dorbala S. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020 Sep 11. PMID: 32918247.
    Citations:    
  2. Dorbala S, Park MA, Cuddy S, Singh V, Sullivan K, Kim S, Falk RH, Taqueti V, Skali H, Blankstein R, Bay C, Kijewski MF, Di Carli MF. Absolute Quantitation of Cardiac 99mTc-pyrophophate Using Cadmium Zinc Telluride-based SPECT/CT. J Nucl Med. 2020 Sep 04. PMID: 32887756.
    Citations:    
  3. Falk RH, Dorbala S. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis. Eur Heart J. 2020 Aug 01; 41(29):2768-2770. PMID: 32638011.
    Citations:    
  4. Cuddy SAM, Dorbala S, Falk RH. Complexities and Pitfalls in Cardiac Amyloidosis. Circulation. 2020 Jul 28; 142(4):409-415. PMID: 32718247.
    Citations:    
  5. Cuddy SAM, Coyle ML, Falk RH. Initial Monthly Cost of Tafamidis-the Real Price for Patients. JAMA Cardiol. 2020 Jul 01; 5(7):847-848. PMID: 32319998.
    Citations:    
  6. Judge DP, Kristen AV, Grogan M, Maurer MS, Falk RH, Hanna M, Gillmore J, Garg P, Vaishnaw AK, Harrop J, Powell C, Karsten V, Zhang X, Sweetser MT, Vest J, Hawkins PN. Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 Jun 16. PMID: 32548685.
    Citations:    
  7. Hanna M, Ruberg FL, Maurer MS, Dispenzieri A, Dorbala S, Falk RH, Hoffman J, Jaber W, Soman P, Witteles RM, Grogan M. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Jun 09; 75(22):2851-2862. PMID: 32498813.
    Citations:    
  8. Judge DP, Kristen AV, Grogan M, Maurer MS, Falk RH, Hanna M, Gillmore J, Garg P, Vaishnaw AK, Harrop J, Powell C, Karsten V, Zhang X, Sweetser MT, Vest J, Hawkins PN. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 06; 34(3):357-370. PMID: 32062791.
    Citations:    
  9. Cuddy SAM, Bravo PE, Falk RH, El-Sady S, Kijewski MF, Park MA, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Cheng SC, Jerosch-Herold M, Kwong RY, Liao R, Dorbala S. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 Jun; 13(6):1325-1336. PMID: 32417333.
    Citations:    
  10. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2020 04; 27(2):659-673. PMID: 31468377.
    Citations:    
  11. Falk RH, Dorbala S. An antibody against pre-amyloid oligomers: a potential clinical tool or merely an intriguing observation? Eur Heart J. 2020 Mar 21; 41(12):1271-1272. PMID: 32047885.
    Citations:    
  12. Vuong J, Singh A, Falk RH, Merchant R, Dorbala S. Geographic variation in public interest about amyloidosis in the United States and English speaking countries. Amyloid. 2020 09; 27(3):210-212. PMID: 32053019.
    Citations:    
  13. Khor YM, Cuddy S, Falk RH, Dorbala S. Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis. Semin Nucl Med. 2020 Jul; 50(4):295-310. PMID: 32540027.
    Citations:    
  14. Cuddy SAM, Falk RH. Amyloidosis as a Systemic Disease in Context. Can J Cardiol. 2020 Mar; 36(3):396-407. PMID: 32145867.
    Citations:    
  15. Fine NM, Falk RH, Davis MK. Cardiac Amyloidosis: We've Come So Far, It's Only the Beginning. Can J Cardiol. 2020 Mar; 36(3):319-321. PMID: 32037106.
    Citations:    
  16. Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park MA, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H, Yee A, Sanchorawala V, Ruberg FL, Liao R, Berk J, Falk RH, Dorbala S. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 Jul; 47(8):1998-2009. PMID: 31807884.
    Citations:    
  17. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2019 12; 26(6):2065-2123. PMID: 31468376.
    Citations:    
  18. Nodoushani A, El-Sady MS, Park MA, Castilloveitia GL, Falk RH, Di Carli MF, Kijewski MF, Dorbala S. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT. J Nucl Cardiol. 2019 Nov 22. PMID: 31758410.
    Citations:    
  19. Dorbala S, Cuddy S, Falk RH. How to Image Cardiac Amyloidosis: A Practical Approach. JACC Cardiovasc Imaging. 2020 Jun; 13(6):1368-1383. PMID: 31607664.
    Citations:    
  20. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. J Card Fail. 2019 Nov; 25(11):e1-e39. PMID: 31473268.
    Citations:    
  21. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. J Card Fail. 2019 Nov; 25(11):854-865. PMID: 31473267.
    Citations:    
  22. Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Heart Fail. 2019 08; 7(8):709-716. PMID: 31302046.
    Citations:    
  23. Gilstrap LG, Dominici F, Wang Y, El-Sady MS, Singh A, Di Carli MF, Falk RH, Dorbala S. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. Circ Heart Fail. 2019 06; 12(6):e005407. PMID: 31170802.
    Citations:    
  24. Minamisawa M, Claggett B, Adams D, Kristen AV, Merlini G, Slama MS, Dispenzieri A, Shah AM, Falk RH, Karsten V, Sweetser MT, Chen J, Riese R, Vest J, Solomon SD. Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study. JAMA Cardiol. 2019 05 01; 4(5):466-472. PMID: 30878017.
    Citations:    
  25. Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 09; 60(9):1234-1239. PMID: 30954943.
    Citations:    
  26. Falk RH. Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end? Eur Heart J. 2019 03 21; 40(12):1009-1012. PMID: 30668704.
    Citations:    Fields:    
  27. Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, Grogan M, Selby VN, Jacoby D, Hanna M, Nativi-Nicolau J, Patel J, Rao S, Sinha U, Turtle CW, Fox JC. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. J Am Coll Cardiol. 2019 07 23; 74(3):285-295. PMID: 30885685.
    Citations:    
  28. Saadalla AM, Singh A, Barnidge D, Kohlhagen M, Merlini G, Falk RH, Murray D. High sensitivity M-protein detection in a case of light-chain cardiac amyloidosis without evidence of plasma cell dyscrasia. Am J Hematol. 2019 05; 94(5):619-621. PMID: 30575105.
    Citations:    Fields:    
  29. Singh V, Falk R, Di Carli MF, Kijewski M, Rapezzi C, Dorbala S. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019 02; 26(1):158-173. PMID: 30569412.
    Citations:    Fields:    
  30. Dorbala S, Falk R. Imaging cardiac amyloidosis: Patient page. J Nucl Cardiol. 2019 02; 26(1):217-221. PMID: 30515743.
    Citations:    Fields:    
  31. Alexander KM, Orav J, Singh A, Jacob SA, Menon A, Padera RF, Kijewski MF, Liao R, Di Carli MF, Laubach JP, Falk RH, Dorbala S. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis. JAMA Cardiol. 2018 09 01; 3(9):865-870. PMID: 30046835.
    Citations:    Fields:    
  32. Bravo PE, Fujikura K, Kijewski MF, Jerosch-Herold M, Jacob S, El-Sady MS, Sticka W, Dubey S, Belanger A, Park MA, Di Carli MF, Kwong RY, Falk RH, Dorbala S. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1165-1173. PMID: 30121266.
    Citations:    Fields:    
  33. Singh A, Falk RH. 'A new staging system for cardiac transthyretin amyloidosis': is it already on the verge of obsolescence? Eur Heart J. 2018 08 07; 39(30):2807-2809. PMID: 29351628.
    Citations:    Fields:    
  34. Singh A, Geller HI, Alexander KM, Padera RF, Mitchell RN, Dorbala S, Castillo JJ, Falk RH. True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis. Haematologica. 2018 08; 103(8):e374-e376. PMID: 29674499.
    Citations:    Fields:    
  35. Geller HI, Singh A, Mirto TM, Padera R, Mitchell R, Laubach JP, Falk RH. Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis. Mayo Clin Proc. 2017 Dec; 92(12):1800-1805. PMID: 29202938.
    Citations: 4     Fields:    Translation:Humans
  36. Nochioka K, Quarta CC, Claggett B, Roca GQ, Rapezzi C, Falk RH, Solomon SD. Left atrial structure and function in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2017 Oct 01; 18(10):1128-1137. PMID: 28637305.
    Citations:    Fields:    Translation:Humans
  37. Falk RH, Dorbala S. Apical to Base Gradient of Technetium-99m Pyrophosphate Myocardial Counts in Cardiac Amyloidosis: An Insight Into the Mechanism of Myocardial Strain Gradient, or Merely "Clouds That Mimic Land Before the Sailor's Eye?" JACC Cardiovasc Imaging. 2018 02; 11(2 Pt 1):243-246. PMID: 28917690.
    Citations:    Fields:    
  38. Geller HI, Singh A, Alexander KM, Mirto TM, Falk RH. Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis. JAMA. 2017 09 12; 318(10):962-963. PMID: 28898370.
    Citations: 1     Fields:    Translation:Humans
  39. Alexander KM, Singh A, Falk RH. Novel pharmacotherapies for cardiac amyloidosis. Pharmacol Ther. 2017 Dec; 180:129-138. PMID: 28648829.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  40. Singh A, Geller HI, Falk RH. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. J Am Coll Cardiol. 2017 02 14; 69(6):757-758. PMID: 28183520.
    Citations:    Fields:    
  41. Divakaran S, Singh A, Collins B, Vita T, Falk RH, Di Carli MF, Blankstein R. Role of Imaging in Evaluating Infiltrative Heart Disease. Curr Treat Options Cardiovasc Med. 2017 Jan; 19(1):3. PMID: 28150064.
    Citations:    
  42. Kassop D, Nam JJ, Cebula BR, Shah P, Blankstein R, Falk RH, Hulten EA. A tale of two diagnoses: The role of noninvasive cardiovascular imaging to differentiate cardiac amyloidosis. J Nucl Cardiol. 2017 12; 24(6):2030-2032. PMID: 27826773.
    Citations:    Fields:    
  43. Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol. 2016 09 20; 68(12):1323-41. PMID: 27634125.
    Citations: 14     Fields:    Translation:Humans
  44. Alexander KM, Falk RH. V122I TTR Cardiac Amyloidosis in Patients of African Descent: Recognizing a Missed Disease or the Dog That Didn't Bark? Circ Heart Fail. 2016 09; 9(9). PMID: 27618856.
    Citations: 1     Fields:    Translation:HumansAnimals
  45. Sivakumar S, Taccone FS, Desai KA, Lazaridis C, Skarzynski M, Sekhon M, Henderson W, Griesdale D, Chapple L, Deane A, Williams L, Strickland R, Lange K, Heyland D, Chapman M, Rowland MJ, Garry P, Westbrook J, Corkill R, Antoniades CA, Pattinson KT, Fatania G, Strong AJ, Myers RB, Lazaridis C, Jermaine CM, Robertson CS, Rusin CG, Hofmeijer J, Sondag L, Tjepkema-Cloostermans MC, Beishuizen A, Bosch FH, van Putten MJ, Carteron L, Patet C, Solari D, Oddo M, Ali MA, Dias C, Almeida R, Vaz-Ferreira A, Silva J, Monteiro E, Cerejo A, Rocha AP, Elsayed AA, Abougabal AM, Beshey BN, Alzahaby KM, Pozzebon S, Ortiz AB, Cristallini S, Lheureux O, Brasseur A, Vincent JL, Creteur J, Taccone FS, Hravnak M, Yousef K, Chang Y, Crago E, Friedlander RM, Abdelmonem SA, Tahon SA, Helmy TA, Meligy HS, Puig F, Dunn-Siegrist I, Pugin J, Gupta S, Govil D, Srinivasan S, Patel SJ, N JK, Gupta A, Tomar DS, Shafi M, Harne R, Arora DP, Talwar N, Mazumdar S, Papakrivou EE, Makris D, Manoulakas E, Tsolaki B, Karadodas B, Zakynthinos E, Garcia IP, Martin AD, Encinares VS, Ibañez MP, Montero JG, Labrador G, Cangueiro TC, Poulose V, Koh J, Kam JW, Yeter H, Kara A, Aktepe O, Topeli A, Tsolakoglou I, Intas G, Stergiannis P, Kolaros AA, Chalari E, Athanasiadou E, Martika A, Fildisis G, Faivre V, Mengelle C, Favier B, Payen D, Poppe A, Winkler MS, Mudersbach E, Schreiber J, Wruck ML, Schwedhelm E, Kluge S, Zöllner C, Tavladaki T, Spanaki AM, Dimitriou H, Kondili E, Choulaki C, Meleti E, Kafetzopoulos D, Georgopoulos D, Briassoulis G, la Torre AG, de la Torre-Prados MV, Tsvetanova-Spasova T, Nuevo-Ortega P, Rueda-Molina C, Fernández-Porcel A, Camara-Sola E, Salido-Díaz L, García-Alcántara A, Tavladaki T, Spanaki AM, Dimitriou H, Kondili E, Choulaki C, Meleti DE, Kafetzopoulos D, Georgopoulos D, Briassoulis G, Suberviola B, Riera J, Rellan L, Sanchez M, Robles JC, Lopez E, Vicente R, Miñambres E, Santibañez M, Le Guen M, Moore J, Mason N, Windpassinger M, Plattner O, Mascha E, Sessler DI, Research O, Melia U, Fontanet J, van den Berg JP, Struys MM, Vereecke HE, Jensen EW, Rood PJ, van de Schoor F, van Tertholen K, Pickkers P, van den Boogaard M, Beardow ZJ, Redhead H, Paramasivam K, Numan T, van den Boogaard M, Kamper AM, Rood P, Peelen LM, Zeman PM, Slooter AJ, van Ewijk CE, Jacobs GE, Girbes AR, Myatra SN, Harish MM, Prabu NR, Siddiqui S, Kulkarni AP, Divatia JV, Murbach LD, Leite MA, Osaku EF, Costa CR, Pelenz M, Neitzke NM, Moraes MM, Jaskowiak JL, Silva MM, Zaponi RS, Abentroth LR, Ogasawara SM, Jorge AC, Duarte PA, Hernández-Sánchez N, Sánchez-Hurtado LA, García-Guillen FJ, Ñamendys-Silva SA, Maghsoudi B, Emami M, Khosravi MB, Zand F, Tabatabaie HR, Masjedi M, Sabetiyan G, Mokri A, Troubleyn J, Diltoer M, Jacobs R, Nguyen DN, De Waele E, De Regt J, Honoré PM, Van Gorp V, Spapen HD, Contreras RS, Toapanta ND, Moreno G, Sabater J, Torrado H, Gonzalez M, Marin M, Farigola E, Gonzalez A, Fernandez J, Vera A, Gisbert X, Juliá C, Uya J, Corral L, Elias-Jones I, Gemmell L, MacKay A, Randall D, Adwaney A, Blunden M, Prowle JR, Kirwan CJ, Thomas N, Martin A, Owen H, Darwin L, Conway D, Atkinson D, Sharman M, Moore J, Barbanti C, Amour J, Gaudard P, Rozec B, Mauriat P, M'rini M, Leger PL, Cambonie G, Liet JM, Girard C, Laroche S, Damas P, Assaf Z, Loron G, Lecourt L, Pouard P, Randall D, Adwaney A, Blunden M, Prowle JR, Kirwan CJ, Kim SH, Na S, Kim J, Oh SY, Jung CW, Yoo SH, Min SH, Chung EJ, Lee H, Lee NJ, Lee KW, Suh KS, Ryu HG, Marshall DC, Goodson RJ, Salciccioli JD, Shalhoub J, Potter EK, Kirk-Bayley J, Karanjia ND, Forni LG, Creagh-Brown BC, Bossy M, Nyman M, Tailor A, Creagh-Brown B, D'Antini D, Spadaro S, Valentino F, Sollitto F, Cinnella G, Mirabella L, Calvo FJ, Bejarano N, Padilla D, Baladron V, Villajero P, Villazala R, Redondo J, Yuste AS, Liu J, Shen F, Teboul JL, Anguel N, Beurton A, Bezaz N, Richard C, Monnet X, Fossali T, Colombo R, Ottolina D, Rossetti M, Mazzucco C, Marchi A, Porta A, Catena E, Tollisen KH, Andersen GØ, Heyerdahl F, Jacobsen D, et al. ESICM LIVES 2016: part two : Milan, Italy. 1-5 October 2016. Intensive Care Med Exp. 2016 Sep; 4(Suppl 1):30. PMID: 27686460.
    Citations:    
  46. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133(24):2404-12. PMID: 27143678.
    Citations: 64     Fields:    Translation:Humans
  47. Falk RH. Pondering the Prognosis and Pathology of Cardiac Amyloidosis: Answers Breed Questions. JACC Cardiovasc Imaging. 2016 Feb; 9(2):139-41. PMID: 26777215.
    Citations:    Fields:    Translation:Humans
  48. Barbhaiya CR, Kumar S, Baldinger SH, Michaud GF, Stevenson WG, Falk R, John RM. Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy. Heart Rhythm. 2016 Feb; 13(2):383-90. PMID: 26400855.
    Citations: 1     Fields:    Translation:Humans
  49. Park MA, Padera RF, Belanger A, Dubey S, Hwang DH, Veeranna V, Falk RH, Di Carli MF, Dorbala S. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015 Aug; 8(8). PMID: 26259579.
    Citations: 10     Fields:    Translation:HumansCells
  50. Kwong RY, Heydari B, Abbasi S, Steel K, Al-Mallah M, Wu H, Falk RH. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function. Am J Cardiol. 2015 Aug 15; 116(4):622-9. PMID: 26076990.
    Citations: 6     Fields:    Translation:Humans
  51. Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med. 2015 May; 7(5):688. PMID: 25940533.
    Citations: 2     Fields:    
  52. Quarta CC, Falk RH, Solomon SD. V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015 04 30; 372(18):1769. PMID: 25923562.
    Citations:    Fields:    Translation:Humans
  53. Maurer MS, Grogan DR, Judge DP, Mundayat R, Packman J, Lombardo I, Quyyumi AA, Aarts J, Falk RH. Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circ Heart Fail. 2015 May; 8(3):519-26. PMID: 25872787.
    Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
  54. Falk RH, Quarta CC. Echocardiography in cardiac amyloidosis. Heart Fail Rev. 2015 Mar; 20(2):125-31. PMID: 25597027.
    Citations: 1     Fields:    Translation:Humans
  55. Quarta CC, Buxbaum JN, Shah AM, Falk RH, Claggett B, Kitzman DW, Mosley TH, Butler KR, Boerwinkle E, Solomon SD. The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015 Jan 01; 372(1):21-9. PMID: 25551524.
    Citations: 25     Fields:    Translation:Humans
  56. Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med. 2014 Nov; 6(11):1493-507. PMID: 25319546.
    Citations: 23     Fields:    Translation:AnimalsCells
  57. Falk RH. "Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanisms. JACC Heart Fail. 2014 Aug; 2(4):425. PMID: 25103981.
    Citations:    Fields:    Translation:Humans
  58. Dorbala S, Vangala D, Bruyere J, Quarta C, Kruger J, Padera R, Foster C, Hanley M, Di Carli MF, Falk R. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014 Aug; 2(4):358-67. PMID: 25023822.
    Citations: 13     Fields:    Translation:Humans
  59. Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR, Di Carli MF, Moore SC, Falk RH. Imaging cardiac amyloidosis: a pilot study using ¹8F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014 Sep; 41(9):1652-62. PMID: 24841414.
    Citations: 39     Fields:    Translation:HumansCTClinical Trials
  60. Falk RH, Quarta CC, Dorbala S. How to image cardiac amyloidosis. Circ Cardiovasc Imaging. 2014 May; 7(3):552-62. PMID: 24847009.
    Citations: 18     Fields:    Translation:Humans
  61. Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, Gagliardi C, Milandri A, Rapezzi C, Falk RH. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation. 2014 May 06; 129(18):1840-9. PMID: 24563469.
    Citations: 25     Fields:    Translation:Humans
  62. Falk RH. AL amyloidosis or multiple myeloma? An important distinction. Br J Haematol. 2014 Mar; 164(5):748-9. PMID: 24261595.
    Citations:    Fields:    Translation:Humans
  63. Guan J, Mishra S, Shi J, Plovie E, Qiu Y, Cao X, Gianni D, Jiang B, Del Monte F, Connors LH, Seldin DC, Lavatelli F, Rognoni P, Palladini G, Merlini G, Falk RH, Semigran MJ, Dec GW, Macrae CA, Liao R. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol. 2013 Sep; 108(5):378. PMID: 23982491.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  64. Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, MacRae CA, Liao R. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol. 2013 Jul 01; 305(1):H95-103. PMID: 23624626.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  65. Quarta CC, Falk RH. A transthyretin variant, Asp18Asn, associated with amyloid cardiomyopathy: a new African-American variant? Amyloid. 2012 Dec; 19(4):204-7. PMID: 23126592.
    Citations:    Fields:    Translation:Humans
  66. Quarta CC, Kruger JL, Falk RH. Cardiac amyloidosis. Circulation. 2012 Sep 18; 126(12):e178-82. PMID: 22988049.
    Citations: 16     Fields:    Translation:HumansCells
  67. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging. 2012 Sep; 5(9):897-907. PMID: 22974802.
    Citations: 37     Fields:    Translation:HumansCells
  68. Quarta CC, Falk RH. Longitudinal strain imaging in light-chain cardiac amyloidosis: can it help to refine the approach to treatment? J Am Coll Cardiol. 2012 Sep 18; 60(12):1077-8. PMID: 22883633.
    Citations: 1     Fields:    Translation:Humans
  69. Ruberg FL, Maurer MS, Judge DP, Zeldenrust S, Skinner M, Kim AY, Falk RH, Cheung KN, Patel AR, Pano A, Packman J, Grogan DR. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J. 2012 Aug; 164(2):222-228.e1. PMID: 22877808.
    Citations: 37     Fields:    Translation:Humans
  70. Falk RH. Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques? Amyloid. 2012 Jun; 19 Suppl 1:68-70. PMID: 22620969.
    Citations: 3     Fields:    Translation:Humans
  71. Philippakis AA, Falk RH. Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide. Circulation. 2012 Apr 10; 125(14):1821-4. PMID: 22492950.
    Citations: 4     Fields:    Translation:Humans
  72. Comenzo RL, Reece D, Palladini G, Seldin D, Sanchorawala V, Landau H, Falk R, Wells K, Solomon A, Wechalekar A, Zonder J, Dispenzieri A, Gertz M, Streicher H, Skinner M, Kyle RA, Merlini G. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia. 2012 Nov; 26(11):2317-25. PMID: 22475872.
    Citations: 36     Fields:    Translation:Humans
  73. Falk RH. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2012 03 22; 366(12):1159-60; author reply 1161. PMID: 22435379.
    Citations:    Fields:    Translation:Humans
  74. Girouard SD, Falk RH, Rennke HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J. 2012 Jan 15; 18(1):2. PMID: 22301039.
    Citations: 6     Fields:    Translation:Humans
  75. Falk RH. Letter by Falk regarding article, "An unusual heart failure: cardiac amyloidosis due to light chain myeloma". Circulation. 2011 Nov 15; 124(20):e534; author reply e535. PMID: 22083153.
    Citations:    Fields:    Translation:Humans
  76. Guan J, Mishra S, Falk RH, Liao R. Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol. 2012 Feb 01; 302(3):H544-52. PMID: 22058156.
    Citations: 20     Fields:    Translation:HumansCells
  77. Falk RH. Cardiac amyloidosis: a treatable disease, often overlooked. Circulation. 2011 Aug 30; 124(9):1079-85. PMID: 21875922.
    Citations: 32     Fields:    Translation:Humans
  78. Rajab TK, Shekar P, Falk RH. Myxoma, dyspnoea, tinnitus, scoliosis, and alopecia. Lancet. 2011 Apr 16; 377(9774):1378. PMID: 21497702.
    Citations: 2     Fields:    Translation:Humans
  79. Falk RH, Dorbala S. Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis. Eur J Nucl Med Mol Imaging. 2011 Mar; 38(3):467-9. PMID: 21267559.
    Citations:    Fields:    Translation:Humans
  80. Falk RH. Pulmonary venous isolation for atrial fibrillation in severe systolic heart failure: more questions than answers? Heart. 2011 May; 97(9):687-8. PMID: 21282135.
    Citations:    Fields:    Translation:Humans
  81. Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011 Jan; 97(1):75-84. PMID: 21148582.
    Citations: 26     Fields:    Translation:Humans
  82. Miller AL, Falk RH, Levy BD, Loscalzo J. Clinical problem-solving. A heavy heart. N Engl J Med. 2010 Oct 07; 363(15):1464-9. PMID: 20925549.
    Citations: 1     Fields:    Translation:Humans
  83. Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging. 2010 Apr; 3(4):333-42. PMID: 20394893.
    Citations: 38     Fields:    Translation:Humans
  84. Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran MJ, Macgillivray TE, Seldin DC, Falk R, Liao R. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A. 2010 Mar 02; 107(9):4188-93. PMID: 20150510.
    Citations: 68     Fields:    Translation:HumansCells
  85. Dubrey SW, Falk RH. Amyloid heart disease. Br J Hosp Med (Lond). 2010 Feb; 71(2):76-82. PMID: 20220694.
    Citations: 3     Fields:    Translation:Humans
  86. Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):336-46. PMID: 20109603.
    Citations: 25     Fields:    Translation:Humans
  87. Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):347-61. PMID: 20109604.
    Citations: 46     Fields:    Translation:Humans
  88. Falk RH, Elkayam U. Cardiomyopathy: the importance of recognizing the uncommon diagnosis. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):262-3. PMID: 20109596.
    Citations: 1     Fields:    Translation:Humans
  89. Falk RH. Severe hypercalcaemia mimicking acute myocardial infarction. Clin Med (Lond). 2009 Oct; 9(5):503-4; author reply 504. PMID: 19891057.
    Citations: 1     Fields:    Translation:Humans
  90. Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J. 2009 Oct; 158(4):607-14. PMID: 19781421.
    Citations: 28     Fields:    Translation:Humans
  91. Falk RH, Camm AJ. Rethinking the reasons to treat atrial fibrillation? The role of dronedarone in reducing cardiovascular hospitalizations. Eur Heart J. 2009 Oct; 30(20):2438-40. PMID: 19744955.
    Citations: 1     Fields:    Translation:Humans
  92. Falk RH. Driving and ventricular arrhythmia: a historical perspective. J Am Coll Cardiol. 2008 Jul 22; 52(4):316; author reply 317. PMID: 18634990.
    Citations:    Fields:    Translation:Humans
  93. Falk RH. Ethnic disparity in intracranial hemorrhage among anticoagulated patients with atrial fibrillation: an answer in search of a question? J Am Coll Cardiol. 2007 Jul 24; 50(4):316-8. PMID: 17659198.
    Citations: 1     Fields:    Translation:Humans
  94. Falk RH. Atrial fibrillation or sinus rhythm? Controversy and contradiction in quality of life outcomes. J Am Coll Cardiol. 2006 Aug 15; 48(4):731-3. PMID: 16904541.
    Citations: 1     Fields:    Translation:Humans
  95. Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Möller W, Sommerer K, Larsson S, Svartengren M. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J. 2006 Aug; 28(2):286-90. PMID: 16641121.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  96. Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid. 2005 Dec; 12(4):210-5. PMID: 16399645.
    Citations: 3     Fields:    Translation:Humans
  97. Nordlinger M, Magnani B, Skinner M, Falk RH. Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol. 2005 Oct 01; 96(7):982-4. PMID: 16188528.
    Citations: 9     Fields:    Translation:Humans
  98. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005 Sep 27; 112(13):2047-60. PMID: 16186440.
    Citations: 116     Fields:    Translation:Humans
  99. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005 Aug; 79(4):319-28. PMID: 16044444.
    Citations: 180     Fields:    Translation:Humans
  100. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med. 2005 Jun 27; 165(12):1425-9. PMID: 15983293.
    Citations: 58     Fields:    Translation:Humans
  101. Falk RH. Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation. Circulation. 2005 Jun 14; 111(23):3141-50; discussion 3157. PMID: 15956148.
    Citations: 6     Fields:    Translation:Humans
  102. Ogiwara F, Koyama J, Ikeda S, Kinoshita O, Falk RH. Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol. 2005 Feb 15; 95(4):538-40. PMID: 15695150.
    Citations: 7     Fields:    Translation:Humans
  103. Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005 Jan 18; 111(2):122-4. PMID: 15657385.
    Citations: 13     Fields:    Translation:Humans
  104. Falk RH. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation. J Am Coll Cardiol. 2004 Oct 19; 44(8):1567-9. PMID: 15489086.
    Citations: 1     Fields:    Translation:Humans
  105. Ezekowitz MD, Falk RH. The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc. 2004 Jul; 79(7):904-13. PMID: 15244388.
    Citations: 8     Fields:    Translation:Humans
  106. Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J. 2004 Jul; 148(1):157-64. PMID: 15215806.
    Citations: 51     Fields:    Translation:HumansCTClinical Trials
  107. Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 2004 Sep 15; 104(6):1888-93. PMID: 15155460.
    Citations: 25     Fields:    Translation:HumansCTClinical Trials
  108. Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant. 2004 Feb; 33(4):381-8. PMID: 14676787.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  109. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004 Jan 20; 140(2):85-93. PMID: 14734330.
    Citations: 108     Fields:    Translation:HumansCTClinical Trials
  110. Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr. 2004 Jan; 17(1):36-44. PMID: 14712185.
    Citations: 12     Fields:    Translation:Humans
  111. Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003 Sep; 124(3):969-77. PMID: 12970025.
    Citations: 19     Fields:    Translation:Humans
  112. Singh SN, Singh BN, Reda DJ, Fye CL, Ezekowitz MD, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Antman EM, Falk RH, Lopez B, Tang XC. Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). Am J Cardiol. 2003 Aug 15; 92(4):468-72. PMID: 12914883.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  113. O'Hara CJ, Falk RH. The diagnosis and typing of cardiac amyloidosis. Amyloid. 2003 Jun; 10(2):127-9. PMID: 12964421.
    Citations: 7     Fields:    Translation:Humans
  114. Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol. 2003 Jun; 53(6):725-30. PMID: 12783418.
    Citations: 14     Fields:    Translation:HumansCells
  115. Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003 May 20; 107(19):2446-52. PMID: 12743000.
    Citations: 72     Fields:    Translation:HumansCTClinical Trials
  116. Falk RH. Adenosine-induced ventricular flutter? Am J Emerg Med. 2003 May; 21(3):249. PMID: 12892107.
    Citations:    Fields:    Translation:Humans
  117. Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V. Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma. 2003 Mar; 3(4):241-6. PMID: 12672274.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  118. Falk RH. Management of atrial fibrillation--radical reform or modest modification? N Engl J Med. 2002 Dec 05; 347(23):1883-4. PMID: 12466514.
    Citations: 4     Fields:    Translation:Humans
  119. Falk RH. Ventricular rate control in the elderly: is digoxin enough? Am J Geriatr Cardiol. 2002 Nov-Dec; 11(6):353-6. PMID: 12417840.
    Citations: 4     Fields:    Translation:Humans
  120. Koyama J, Ray-Sequin PA, Falk RH. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation. 2002 Jul 30; 106(5):556-61. PMID: 12147536.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  121. Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol. 2002 Jun; 117(4):886-9. PMID: 12060126.
    Citations: 7     Fields:    Translation:Humans
  122. Lim A, Prokaeva T, Connor LH, Falk RH, Skinner M, Costello CE. Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid. 2002 Jun; 9(2):134-40. PMID: 12440486.
    Citations: 4     Fields:    Translation:Humans
  123. Koyama J, Ray-Sequin PA, Davidoff R, Falk RH. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol. 2002 May 01; 89(9):1067-71. PMID: 11988197.
    Citations: 17     Fields:    Translation:Humans
  124. Falk RH. The neglected entity of familial cardiac amyloidosis in African Americans. Ethn Dis. 2002; 12(1):141-3. PMID: 11913602.
    Citations: 2     Fields:    Translation:Humans
  125. Khan MF, Falk RH. Amyloidosis. Postgrad Med J. 2001 Nov; 77(913):686-93. PMID: 11677276.
    Citations: 14     Fields:    Translation:Humans
  126. Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, Falk RH, Apstein CS. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation. 2001 Oct 02; 104(14):1594-7. PMID: 11581134.
    Citations: 56     Fields:    Translation:HumansAnimals
  127. Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001 Oct; 28(7):637-42. PMID: 11704785.
    Citations: 22     Fields:    Translation:Humans
  128. Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med. 2001 May 01; 134(9 Pt 1):746-53. PMID: 11329232.
    Citations: 14     Fields:    Translation:Humans
  129. Falk RH. Atrial fibrillation. N Engl J Med. 2001 Apr 05; 344(14):1067-78. PMID: 11287978.
    Citations: 67     Fields:    Translation:Humans
  130. Falk RH. The cardiovascular response to sexual activity: do we know enough? Clin Cardiol. 2001 Apr; 24(4):271-5. PMID: 11303692.
    Citations: 1     Fields:    Translation:Humans
  131. Matsui K, Beasley MB, Nelson WK, Barnes PM, Bechtle J, Falk R, Ferrans VJ, Moss J, Travis WD. Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol. 2001 Apr; 25(4):479-84. PMID: 11257622.
    Citations: 23     Fields:    Translation:HumansCells
  132. Falk RH, Decara JM. Dofetilide: a new pure class III antiarrhythmic agent. Am Heart J. 2000 Nov; 140(5):697-706. PMID: 11054613.
    Citations: 3     Fields:    Translation:HumansAnimals
  133. DeCara JM, Pollak A, Dubrey S, Falk RH. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. Am J Cardiol. 2000 Sep 15; 86(6):685-8, A8. PMID: 10980226.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  134. Murphy L, Falk RH. Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction? Am J Cardiol. 2000 Jul 15; 86(2):244-6. PMID: 10913497.
    Citations: 2     Fields:    Translation:Humans
  135. Khan MF, Falk RH. S1 in Wolff-Parkinson-White syndrome. Am J Cardiol. 2000 Jun 15; 85(12):1510. PMID: 10939982.
    Citations:    Fields:    Translation:Humans
  136. Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med. 2000; 45:107-37. PMID: 10635047.
    Citations: 17     Fields:    Translation:Humans
  137. Connors LH, Théberge R, Skare J, Costello CE, Falk RH, Skinner M. A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid. 1999 Jun; 6(2):114-8. PMID: 10439117.
    Citations: 4     Fields:    Translation:Humans
  138. Théberge R, Connors L, Skare J, Skinner M, Falk RH, Costello CE. A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient. Amyloid. 1999 Mar; 6(1):54-8. PMID: 10211412.
    Citations: 2     Fields:    Translation:Humans
  139. Comenzo RL, Sanchorawala V, Fisher C, Akpek G, Farhat M, Cerda S, Berk JL, Dember LM, Falk R, Finn K, Skinner M, Vosburgh E. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis. Br J Haematol. 1999 Mar; 104(3):553-9. PMID: 10086794.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  140. Falk RH. Etiology and complications of atrial fibrillation: insights from pathology studies. Am J Cardiol. 1998 Oct 16; 82(8A):10N-17N. PMID: 9809896.
    Citations: 8     Fields:    Translation:Humans
  141. Eckman MH, Falk RH, Pauker SG. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med. 1998 Aug 10-24; 158(15):1669-77. PMID: 9701102.
    Citations: 9     Fields:    Translation:Humans
  142. Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'hara C, Arkin CF, Wright DG, Skinner M. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998 May 15; 91(10):3662-70. PMID: 9573002.
    Citations: 34     Fields:    Translation:HumansCTClinical Trials
  143. Falk RH, Decara J, Abascal V. Is pharmacologic cardioversion of atrial fibrillation really preferable to electrical cardioversion? J Am Coll Cardiol. 1998 May; 31(6):1446-7. PMID: 9581752.
    Citations:    Fields:    Translation:Humans
  144. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, Falk RH, Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 1998 Apr 15; 65(7):918-25. PMID: 9565095.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  145. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998 Feb; 91(2):141-57. PMID: 9578896.
    Citations: 88     Fields:    Translation:Humans
  146. DeCara JM, Croze S, Falk RH. Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card? Chest. 1998 Feb; 113(2):261-3. PMID: 9498932.
    Citations: 4     Fields:    Translation:Humans
  147. Dubrey SW, Bilazarian S, LaValley M, Reisinger J, Skinner M, Falk RH. Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. Am Heart J. 1997 Dec; 134(6):994-1001. PMID: 9424057.
    Citations: 7     Fields:    Translation:Humans
  148. Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol. 1997 Nov 01; 80(9):1242-5. PMID: 9359565.
    Citations: 12     Fields:    Translation:Humans
  149. Reisinger J, Dubrey SW, Lavalley M, Skinner M, Falk RH. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol. 1997 Oct; 30(4):1046-51. PMID: 9316537.
    Citations: 11     Fields:    Translation:Humans
  150. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997 Sep 25; 337(13):898-909. PMID: 9302305.
    Citations: 189     Fields:    Translation:Humans
  151. Patel AR, Dubrey SW, Mendes LA, Skinner M, Cupples A, Falk RH, Davidoff R. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol. 1997 Aug 15; 80(4):486-92. PMID: 9285663.
    Citations: 9     Fields:    Translation:Humans
  152. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation. 1997 Jul 15; 64(1):74-80. PMID: 9233704.
    Citations: 17     Fields:    Translation:Humans
  153. Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart. 1997 Jul; 78(1):74-82. PMID: 9290406.
    Citations: 29     Fields:    Translation:Humans
  154. Reisinger J, Dubrey SW, Falk RH. Restrictive cardiomyopathy. N Engl J Med. 1997 Jun 26; 336(26):1917; author reply 1917-8. PMID: 9198760.
    Citations: 1     Fields:    Translation:Humans
  155. Falk RH, Pollak A, Singh SN, Friedrich T. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol. 1997 Feb; 29(2):385-90. PMID: 9014993.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  156. Reisinger J, Falk RH. Clinical value of a new Doppler index in cardiac amyloidosis. J Am Coll Cardiol. 1997 Feb; 29(2):471-2. PMID: 9015010.
    Citations: 1     Fields:    Translation:Humans
  157. Dubrey SW, Falk RH. Optimal number of beats for the Doppler measurement of cardiac output in atrial fibrillation. J Am Soc Echocardiogr. 1997 Jan-Feb; 10(1):67-71. PMID: 9046495.
    Citations: 13     Fields:    Translation:Humans
  158. Falk RH. Pharmacologic control of heart rate in atrial fibrillation. Cardiol Clin. 1996 Nov; 14(4):521-36. PMID: 8950054.
    Citations: 1     Fields:    Translation:Humans
  159. Comenzo RL, Vosburgh E, Simms RW, Bergethon P, Sarnacki D, Finn K, Dubrey S, Faller DV, Wright DG, Falk RH, Skinner M. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood. 1996 Oct 01; 88(7):2801-6. PMID: 8839879.
    Citations: 26     Fields:    Translation:HumansCTClinical Trials
  160. Dubrey S, Mendes L, Skinner M, Falk RH. Resolution of heart failure in patients with AL amyloidosis. Ann Intern Med. 1996 Sep 15; 125(6):481-4. PMID: 8779461.
    Citations: 9     Fields:    Translation:Humans
  161. Dubrey S, Falk RH. QT interval in cardiac amyloidosis. Clin Cardiol. 1996 May; 19(5):A22, 442. PMID: 8723590.
    Citations:    Fields:    Translation:Humans
  162. Cleland JG, Cowburn PJ, Falk RH. Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials. Eur Heart J. 1996 May; 17(5):674-81. PMID: 8737097.
    Citations: 4     Fields:    Translation:Humans
  163. Cha K, Falk RH. Images in clinical medicine. Pulsus alternans. N Engl J Med. 1996 Mar 28; 334(13):834. PMID: 8596550.
    Citations:    Fields:    Translation:Humans
  164. Skinner M, Anderson J, Simms R, Falk R, Wang M, Libbey C, Jones LA, Cohen AS. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996 Mar; 100(3):290-8. PMID: 8629674.
    Citations: 37     Fields:    Translation:HumansCTClinical Trials
  165. Dubrey SW, Cha K, Simms RW, Skinner M, Falk RH. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol. 1996 Feb 01; 77(4):313-5. PMID: 8607418.
    Citations: 20     Fields:    Translation:Humans
  166. Dubrey S, Falk R. Thyrotoxicosis and dilated cardiomyopathy. Am Heart J. 1995 Dec; 130(6):1314-5. PMID: 7484799.
    Citations:    Fields:    Translation:Humans
  167. Falk RH. A posterior mediastinal mass diagnosed by echocardiogram. Chest. 1995 Nov; 108(5):1447-8. PMID: 7587456.
    Citations:    Fields:    Translation:Humans
  168. Dubrey S, Pollak A, Skinner M, Falk RH. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J. 1995 Nov; 74(5):541-4. PMID: 8562243.
    Citations: 14     Fields:    Translation:Humans
  169. Dubrey S, Simms RW, Skinner M, Falk RH. Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival. Am J Cardiol. 1995 Oct 01; 76(10):739-41. PMID: 7572642.
    Citations: 5     Fields:    Translation:Humans
  170. Cleland JG, Bulpitt CJ, Falk RH, Findlay IN, Oakley CM, Murray G, Poole-Wilson PA, Prentice CR, Sutton GC. Is aspirin safe for patients with heart failure? Br Heart J. 1995 Sep; 74(3):215-9. PMID: 7547012.
    Citations: 16     Fields:    Translation:Humans
  171. Falk RH. Images in clinical medicine. The "thumb sign" in Marfan's syndrome. N Engl J Med. 1995 Aug 17; 333(7):430. PMID: 7616992.
    Citations: 1     Fields:    Translation:Humans
  172. Dubrey S, Falk RH. Palpitations in idiopathic dilated cardiomyopathy. Am J Cardiol. 1995 May 15; 75(15):1081. PMID: 7747695.
    Citations:    Fields:    Translation:Humans
  173. Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. Am Heart J. 1995 Apr; 129(4):739-48. PMID: 7900626.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  174. Falk RH. A response to the letter on electrical cardioversion resulting in death from synchronization failure. Am J Cardiol. 1995 Mar 01; 75(7):551. PMID: 7864016.
    Citations:    Fields:    Translation:Humans
  175. Pollak A, Falk RH. Aggravation of postcardioversion atrial dysfunction by sotalol. J Am Coll Cardiol. 1995 Mar 01; 25(3):665-71. PMID: 7860911.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  176. Falk RH, Fogel RI. Flecainide. J Cardiovasc Electrophysiol. 1994 Nov; 5(11):964-81. PMID: 7889236.
    Citations: 4     Fields:    Translation:Humans
  177. Falk RH, Pollak A. Signal-averaged P wave duration and atrial fibrillation. J Am Coll Cardiol. 1994 Feb; 23(2):549-50. PMID: 8294715.
    Citations:    Fields:    Translation:Humans
  178. Skinner M, Lewis WD, Jones LA, Kasirsky J, Kane K, Ju ST, Jenkins R, Falk RH, Simms RW, Cohen AS. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med. 1994 Jan 15; 120(2):133-4. PMID: 8256972.
    Citations: 10     Fields:    Translation:Humans
  179. Falk RH. Current management of atrial fibrillation. Curr Opin Cardiol. 1994 Jan; 9(1):30-9. PMID: 8199369.
    Citations: 1     Fields:    Translation:HumansAnimals
  180. Falk RH, Battinelli NJ. External cardiac pacing using low impedance electrodes suitable for defibrillation: a comparative blinded study. J Am Coll Cardiol. 1993 Nov 01; 22(5):1354-8. PMID: 8227791.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  181. Pollak A, Falk RH. Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest. 1993 Aug; 104(2):618-20. PMID: 8339658.
    Citations: 14     Fields:    Translation:Humans
  182. Falk RH. A piece of my mind. Cognocardiology. JAMA. 1993 May 26; 269(20):2601. PMID: 8487428.
    Citations:    Fields:    
  183. Pollak A, Falk RH. Pacemaker therapy in patients with atrial fibrillation. Am Heart J. 1993 Mar; 125(3):824-30. PMID: 8094937.
    Citations: 4     Fields:    Translation:Humans
  184. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med. 1992 Jul 15; 117(2):141-50. PMID: 1605429.
    Citations: 23     Fields:    Translation:Humans
  185. Pollak A, Falk RH. New criteria for diagnosis of regular, wide-complex tachycardias. Circulation. 1992 May; 85(5):1955-6. PMID: 1572055.
    Citations: 1     Fields:    Translation:Humans
  186. Leavitt JA, Turner AK, Battinelli NJ, Coats MH, Falk RH. Reproducibility of the catecholamine response to serial exercise testing in normals. Am J Med Sci. 1992 Mar; 303(3):160-4. PMID: 1595777.
    Citations:    Fields:    Translation:Humans
  187. Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J. 1992 Jan; 123(1):136-42. PMID: 1729816.
    Citations: 20     Fields:    Translation:Humans
  188. Pollak A, Falk RH. Predictive value of P wave-triggered signal averaging of the electrocardiogram. Circulation. 1991 Dec; 84(6):2606-7. PMID: 1959213.
    Citations:    Fields:    Translation:Humans
  189. Falk RH. Digoxin: mythology or evidence? Ann Intern Med. 1991 Aug 15; 115(4):329. PMID: 1854123.
    Citations:    Fields:    Translation:Humans
  190. Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol. 1991 Jun; 17(7):1520-6. PMID: 2033184.
    Citations: 8     Fields:    Translation:Humans
  191. Falk RH. PFO or UFO? The role of a patent foramen ovale in cryptogenic stroke. Am Heart J. 1991 Apr; 121(4 Pt 1):1264-6. PMID: 2008854.
    Citations: 7     Fields:    Translation:Humans
  192. Falk RH, Leavitt JI. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med. 1991 Apr 01; 114(7):573-5. PMID: 2001090.
    Citations: 15     Fields:    Translation:Humans
  193. Falk RH. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J. 1990 Dec; 64(6):409. PMID: 2271354.
    Citations:    Fields:    Translation:Humans
  194. Knowlton AA, Falk RH. Paradoxical increase in heart rate before conversion to sinus rhythm in patients with recent-onset atrial fibrillation. Am J Cardiol. 1990 Apr 01; 65(13):930-2. PMID: 2321547.
    Citations: 1     Fields:    Translation:Humans
  195. Falk RH. Impact of prospective peer review on pacemaker implantation rates in Massachusetts. J Am Coll Cardiol. 1990 Apr; 15(5):1087-92. PMID: 2312963.
    Citations: 1     Fields:    Translation:Humans
  196. Falk RH. A plea for a clinical trial of anticoagulation in dilated cardiomyopathy. Am J Cardiol. 1990 Apr 01; 65(13):914-5. PMID: 2181847.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  197. Falk RH. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med. 1989 Jul 15; 111(2):107-11. PMID: 2500880.
    Citations: 15     Fields:    Translation:Humans
  198. Falk RH, Knowlton AA, Battinelli NJ. The effect of propranolol and verapamil on external pacing threshold: a placebo-controlled study. Pacing Clin Electrophysiol. 1988 Oct; 11(10):1439-43. PMID: 2462221.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  199. Falk RH, Knowlton AA, Manaker S. Verapamil-induced atrial fibrillation. N Engl J Med. 1988 Mar 10; 318(10):640-1. PMID: 3344011.
    Citations:    Fields:    Translation:Humans
  200. Falk RH. A nameless obituary. Reflections on the depersonalization of the elderly. Am J Med. 1987 Dec; 83(6):1134. PMID: 3503580.
    Citations:    Fields:    Translation:Humans
  201. Falk RH, Werner M. Transesophageal atrial pacing using a pill electrode for the termination of atrial flutter. Chest. 1987 Jul; 92(1):110-4. PMID: 3595221.
    Citations: 2     Fields:    Translation:Humans
  202. Falk RH, Knowlton AA. Atypical ventricular tachycardia or motion artifact? Am J Cardiol. 1987 Apr 01; 59(8):924. PMID: 3825957.
    Citations:    Fields:    Translation:Humans
  203. Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med. 1987 Apr; 106(4):503-6. PMID: 3548521.
    Citations: 42     Fields:    Translation:HumansCTClinical Trials
  204. Falk RH, Plehn JF, Deering T, Schick EC, Boinay P, Rubinow A, Skinner M, Cohen AS. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol. 1987 Feb 15; 59(5):418-22. PMID: 2949593.
    Citations: 26     Fields:    Translation:Humans
  205. Falk RH. Pseudoparadoxic effect of atropine and carotid sinus massage on atrioventricular conduction in acute myocardial infarction. Chest. 1986 Oct; 90(4):601-3. PMID: 3757570.
    Citations:    Fields:    Translation:Humans
  206. Knowlton AA, Falk RH. External cardiac pacing during in-hospital cardiac arrest. Am J Cardiol. 1986 Jun 01; 57(15):1295-8. PMID: 3717028.
    Citations: 1     Fields:    Translation:Humans
  207. Falk RH. The preliminary communication 'Transcutaneous temporary pacing in the operating room'. JAMA. 1986 May 09; 255(18):2441-2. PMID: 3701950.
    Citations:    Fields:    Translation:Humans
  208. Gertz MA, Falk RH, Skinner M, Cohen AS, Kyle RA. Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol. 1985 Jun 01; 55(13 Pt 1):1645. PMID: 4003314.
    Citations: 24     Fields:    Translation:Humans
  209. Gertz MA, Skinner M, Connors LH, Falk RH, Cohen AS, Kyle RA. Selective binding of nifedipine to amyloid fibrils. Am J Cardiol. 1985 Jun 01; 55(13 Pt 1):1646. PMID: 4003315.
    Citations: 8     Fields:    Translation:Humans
  210. Zoll PM, Zoll RH, Falk RH, Clinton JE, Eitel DR, Antman EM. External noninvasive temporary cardiac pacing: clinical trials. Circulation. 1985 May; 71(5):937-44. PMID: 3886190.
    Citations: 7     Fields:    Translation:HumansAnimalsPHPublic HealthCTClinical Trials
  211. Falk RH, Lee VW, Rubinow A, Skinner M, Cohen AS. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am J Cardiol. 1984 Nov 01; 54(8):1150-1. PMID: 6093493.
    Citations: 2     Fields:    Translation:Humans
  212. Falk RH, O'Brien JL. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias. Chest. 1984 Oct; 86(4):537-40. PMID: 6383741.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  213. Falk RH. Clinical application of external pacing. Am J Emerg Med. 1984 May; 2(3):230-1. PMID: 6518018.
    Citations:    Fields:    Translation:HumansPHPublic Health
  214. Falk RH, Rubinow A, Cohen AS. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol. 1984 Jan; 3(1):107-13. PMID: 6317729.
    Citations: 11     Fields:    Translation:Humans
  215. Falk RH, Zoll PM, Zoll RH. Safety and efficacy of noninvasive cardiac pacing. A preliminary report. N Engl J Med. 1983 Nov 10; 309(19):1166-8. PMID: 6621662.
    Citations: 3     Fields:    Translation:Humans
  216. Sullam PM, Falk RH. Cardiac tamponade with refeeding in malnutrition. Am Heart J. 1983 Aug; 106(2):422-3. PMID: 6869231.
    Citations:    Fields:    Translation:Humans